Skip Navigation


JAC Advance Access originally published online on December 21, 2006
Journal of Antimicrobial Chemotherapy 2007 59(2):321-322; doi:10.1093/jac/dkl481
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
59/2/321    most recent
dkl481v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ellington, M. J.
Right arrow Articles by Woodford, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellington, M. J.
Right arrow Articles by Woodford, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Multiplex PCR for rapid detection of genes encoding acquired metallo-ß-lactamases

Matthew J. Ellington*,{dagger}, James Kistler, David M. Livermore and Neil Woodford

Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London, UK


* Corresponding author. Tel: +44-20-8327-7259; Fax: +44-20-8200-7449; E-mail: matthew.ellington@hpa.org.uk

Keywords: imipenem , carbapenems , acquired resistance , IMP , VIM

The first 10% of the full text of this article appears below.

Sir,

Carbapenems are considered a last-line agent for the treatment of serious Gram-negative sepsis. Metallo-ß-lactamases (MBLs) hydrolyse carbapenems efficiently and, when present, can undermine carbapenem therapy.1 Acquired MBLs have been reported mainly in clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp., sometimes from major clonal outbreaks, as well as in other non-fermenters; they have also been reported, less commonly, in members of the Enterobacteriaceae.2 The acquired MBLs so far described belong to five different families3,4 with multiple variants of the VIM and . . . [Full Text of this Article]

Transparency declarations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
P. G. Higgins, L. Poirel, M. Lehmann, P. Nordmann, and H. Seifert
OXA-143, a Novel Carbapenem-Hydrolyzing Class D {beta}-Lactamase in Acinetobacter baumannii
Antimicrob. Agents Chemother., December 1, 2009; 53(12): 5035 - 5038.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P.-L. Lu, M. Doumith, D. M. Livermore, T.-P. Chen, and N. Woodford
Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase
J. Antimicrob. Chemother., April 1, 2009; 63(4): 641 - 647.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Doumith, M. J. Ellington, D. M. Livermore, and N. Woodford
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
J. Antimicrob. Chemother., April 1, 2009; 63(4): 659 - 667.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
N. Woodford, J. Zhang, M. E. Kaufmann, S. Yarde, M. d. M. Tomas, C. Faris, M. S. Vardhan, S. Dawson, S. L. Cotterill, and D. M. Livermore
Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum {beta}-lactamases in the United Kingdom
J. Antimicrob. Chemother., December 1, 2008; 62(6): 1265 - 1268.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. M. Livermore, R. Hope, G. Brick, M. Lillie, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc
Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii41 - ii54.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. M. Livermore, R. Hope, G. Brick, M. Lillie, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc
Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06
J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii55 - ii63.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Nemec, L. Krizova, M. Maixnerova, L. Diancourt, T. J. K. van der Reijden, S. Brisse, P. van den Broek, and L. Dijkshoorn
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II
J. Antimicrob. Chemother., September 1, 2008; 62(3): 484 - 489.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T.-L. Chen, R. C.-C. Wu, M.-F. Shaio, C.-P. Fung, and W.-L. Cho
Acquisition of a Plasmid-Borne blaOXA-58 Gene with an Upstream IS1008 Insertion Conferring a High Level of Carbapenem Resistance to Acinetobacter baumannii
Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2573 - 2580.
[Abstract] [Full Text] [PDF]